Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 22:00:00
Tilray Brands Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
7,51 0,27 0,02 20 019 869
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiTilray Brands Inc
TickerTLRY
Kmenové akcie:Ordinary Shares
RICTLRY.O
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.05.2025
Poslední známé čtvrtletní výsledky30.11.2025
Počet zaměstnanců k 31.05.2025 2 842
Akcie v oběhu k 06.01.2026 116 506 916
MěnaUSD
Kontaktní informace
Ulice265 Talbot Street West
MěstoLEAMINGTON
PSČN8H 5L4
ZeměCanada
Kontatní osoba 
Funkce kontaktní osoby 
Telefon15 193 228 800
Fax14169342141

Business Summary: Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
Financial Summary: BRIEF: For the six months ended 30 November 2025, Tilray Brands Inc revenues increased 4% to $427M. Net loss decreased 64% to $45.3M. Revenues reflect Distribution Business segment increase from $67.6M to $159.3M, Cannabis Business segment increase from $65.7M to $132M, EMEA segment increase from $79.3M to $188.4M, Canada segment increase of 98% to $112.3M. Lower net loss reflects Amortization decrease of 81% to $8.3M (expense).
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSMedicinal and Botanical Manufacturing
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSDistilleries
NAICSBreweries
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Medicinal & Botanical Mfg
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Distilleries
NAICS2007Breweries
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
NAICS1997Distilleries
NAICS1997Breweries
SICPharmaceutical Preparations
SICMedicinals And Botanicals
SICDrugs/proprietaries/sundries
SICDistilled And Blended Liquors
SICMalt Beverages



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerIrwin Simon6701.05.202101.05.2021
Chief Financial OfficerCarl Merton5601.05.202101.05.2021
Chief Administrative OfficerRoger Savell6331.03.202231.03.2022
Global General Counsel, Corporate SecretaryMitchell Gendel6017.07.202117.07.2021
Chief Strategy Officer, Head - InternationalDenise Faltischek5201.05.202101.05.2021